Smart Money Alert

Mankind Pharma Limited

DecreasedQuarterly

MANKINDPharmaceuticalsMarket Cap₹1.0L Cr

Stake

1.53% → 1.29%

Government Pension Fund Global (Norway)

Foreign Investor

The move

Government Pension Fund Global (Norway) decreased its stake in Mankind Pharma Limited from 1.53% to 1.29% by selling 984,414 shares. The value of the sold shares is approximately ₹233.7 Cr, at a price of ₹2374.50 apiece.

About Mankind Pharma Limited

Visit stock

A pharmaceutical company that develops, manufactures, and markets a diverse range of formulations across acute and chronic therapeutic areas alongside consumer healthcare products. Incorporated in 1995, the company operates through multiple distribution channels and disease segments within India's pharmaceutical market. Its portfolio spans prescription medicines, over-the-counter products, and wellness offerings designed to serve diverse patient populations and healthcare needs.

About Government Pension Fund Global (Norway)

Visit investor

Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.

Get the next move the moment it happens.

Follow Government Pension Fund Global (Norway) and Mankind Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Mankind Pharma Limited shareholders Government Pension Fund Global (Norway)'s portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Mankind Pharma Limited

Axis Mutual FundExited

Axis Mutual Fund, which last reported a 1.32 percent stake in Mankind Pharma Limited, is no longer listed among the company's disclosed shareholders. This indicates either a complete divestment or a reduction of its holding to below the 1 percent disclosure threshold.

21 Jul 2026

Nippon India Mutual FundIncreased

Nippon India Mutual Fund increased its stake in Mankind Pharma from 1.45% to 2.07%, acquiring an additional 2,566,935 shares. The approximate value of the acquired shares is ₹609.19 crore, based on a share price of ₹2374.50.